MBM Successfully Upholds Agreement to Restrict Use of Descriptive Terms

cb photo 104 4ee6a4ed697b9MBM Successfully Upholds Agreement to Restrict Use of Descriptive Terms
Scott Miller, March 23, 2012

Before the Ontario Superior Court of Justice, Scott Miller of MBM Intellectual Property Law LLP, representing Skipper Online Services (SOS) Inc. d.b.a. Boaterexam.com, successfully brought an application (No. 11-52596) to enforce an agreement which restricted 2030564 Ontario Inc. d.b.a. Boatsmart Canada from displaying, amongst other words, EXAMEN DE BATEAU "or any reversals, misspellings, translations or plurals thereof as or in a name or trade-mark, or in any other manner...". Boaterexam.com filed evidence of two interpreters demonstrating that Boatsmart Canada's use of the terms 'BOAT EXAM' and 'BOATING EXAM' can be translated into 'EXAMEN DE BATEAU'. Madame Justice Parfett acknowledged that the terms regardless of their descriptive nature will be restricted from use where an agreement uses plain language such as 'refrain from using' in a 'name', 'trade-mark' or 'in any other manner'.

The Court's willingness to uphold an agreement to restrict Boatsmart Canada from using the terms 'BOAT EXAM' and 'BOATING EXAM' should offer fair warning to all those who enter contracts. It is extremely important to ensure that before a party agrees not to use a translated word that they understand what that word means in the other language, regardless of the descriptive nature of the words. Both parties offer online testing for pleasure craft operating cards.

Submit to DiggSubmit to FacebookSubmit to Google BookmarksSubmit to StumbleuponSubmit to TwitterSubmit to LinkedIn

cb photo 109 5616cbbea0f92

DR. KAY PALMER

Patent Agent


Kay drafts and prosecutes patents in the fields of biochemical, pharmaceutical and molecular biology.
MBM read_more_btn

 

MBM logo

About MBM

 The process of invention is complete only with the IP protection provided in law. That's where MBM comes in. We match our clients' creative thinking with the creative protection needed to achieve their goals.Read More About MBM

Clarifications to the Data Protection Guidance Document

Health Canada recently announced that section 2.1 of its Guidance Document re: Data Protection has been amended to clarify that the prior approval of a medicinal ingredient in a drug for veterinary use will not preclude the granting of data protection for a drug for...Read More